SecBot SecBot

SONM

DNA X, Inc.
Nasdaq· Telephone & Telegraph Apparatus· Inc. DE· CIK 0001178697 Media & Telecom
$2.96 −0.12 (−3.86%)
Oct 26 4:00 PM ET · prev $3.08
Market cap
$4.7M
Nano cap
Next earnings
Oct 29
in 3 days
1 year
−74.0%
from $11.37 · Oct 27
30 days
−32.0%
from $4.35
52-week range
$2.75–11.60
−74% from high · low Dec 30
Avg volume 20D
9.6K
shares / day
Short interest
17.6K
≈1.2% of shares · −16.4%
Days to cover
1.0
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
9
analyzed by SecBot
SecBot read MIXED 3 reports · 90 days
Balance 1 bearish · 1 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 2/3 ·Next Earnings date, Oct 29, 2026
Strongest BULLISH DNA X (SONM) received a Nasdaq Hearings Panel letter confirming it has regained compliance with the minimum…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 0 added (0 new), 1 trimmed or exited.

  • Short sellersCOVERING

    Short interest −16.4% to 17.6K shares. 1.0 days to cover, ≈1.2% of shares.

  • TrendDOWNTREND

    15% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGNEAR_EXIT2,304$11.9K
UBS Group AGDOUBLED36,219$146.0K

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Oct 29, 2026
Earnings date
SONM Q3 2026 Earnings Scheduled — 2026-10-29
Recent
Aug 19, 2026
Earnings
DNA X, Inc. Reports Second Quarter 2026 Financial Results
- Strengthened balance sheet with $1.8 million cash from new convertible debt in Q2 and additional $5.0 million through the sale of preferred stock…
Aug 6, 2026
Earnings date
SONM Q2 2026 Earnings Scheduled — 2026-08-06
May 13, 2026
Earnings date
SONM Q1 2026 Earnings Scheduled — 2026-05-13
May 11, 2026
Earnings date
SONM Q1 2026 Earnings Scheduled — 2026-05-11
Mar 30, 2026
Earnings date
SONM Q4 2025 Earnings After Market Close — 2026-03-30

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Feb 9, 2026
MULICA MICHAEL C
Acting CEO
AWARD50,000 sh
Feb 9, 2026
Crolius Clayton
Chief Financial Officer
AWARD35,000 sh

Earnings setup

Estimates
Oct 29
reports in 3 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Sep 30, 2026
17,581
shares short
-16.4%
vs prior settlement
1.0
days to cover
≈1.2%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 31, 2026 SEC
DNA X (SONM) received a Nasdaq Hearings Panel letter confirming it has regained compliance with the minimum $2.5M…
8-K — Impact 5/10
Aug 27, 2026 SEC
DNA X, Inc. filed an 8-K disclosing that its compensation committee approved a substitute cash grant to all board…
8-K — Impact 2/10
Aug 19, 2026 SEC
DNA X (SONM) reported Q2 2026 results with zero revenue from continuing operations as its AI trading platform remains…
PRESS-RELEASE — Impact 6/10
Aug 19, 2026 Earnings
DNA X, Inc. Reports Second Quarter 2026 Financial Results
- Strengthened balance sheet with $1.8 million cash from new convertible debt in Q2 and additional $
Jun 30, 2026 Inst.
UBS Group AG — NEAR_EXIT
2,304 shares ($11.9K)
Mar 31, 2026 Inst.
UBS Group AG — DOUBLED
36,219 shares ($146.0K)
Feb 9, 2026 Insider
MULICA MICHAEL C was granted 50,000 shares
Acting CEO
Feb 9, 2026 Insider
Crolius Clayton was granted 35,000 shares
Chief Financial Officer

SecBot reports

9 filings · 1 bullish · 5 bearish · 3 neutral
All SONM filing & press-release reports (9)